322 related articles for article (PubMed ID: 20470274)
21. Preventive effect of statin pretreatment on contrast-induced acute kidney injury in patients undergoing coronary angioplasty: propensity score analysis from a multicenter registry.
Hoshi T; Sato A; Kakefuda Y; Harunari T; Watabe H; Ojima E; Hiraya D; Abe D; Nishina H; Takeyasu N; Noguchi Y; Aonuma K
Int J Cardiol; 2014 Feb; 171(2):243-9. PubMed ID: 24393575
[TBL] [Abstract][Full Text] [Related]
22. The incidence of contrast-induced nephropathy in trauma patients.
Hipp A; Desai S; Lopez C; Sinert R
Eur J Emerg Med; 2008 Jun; 15(3):134-9. PubMed ID: 18460952
[TBL] [Abstract][Full Text] [Related]
23. Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention.
Tan N; Liu Y; Zhou YL; He PC; Yang JQ; Luo JF; Chen JY
Catheter Cardiovasc Interv; 2012 Jan; 79(1):70-5. PubMed ID: 21990069
[TBL] [Abstract][Full Text] [Related]
24. Prevention of contrast-induced nephropathy by chronic pravastatin treatment in patients with cardiovascular disease and renal insufficiency.
Yoshida S; Kamihata H; Nakamura S; Senoo T; Manabe K; Motohiro M; Sugiura T; Iwasaka T
J Cardiol; 2009 Oct; 54(2):192-8. PubMed ID: 19782255
[TBL] [Abstract][Full Text] [Related]
25. Diabetic patients with normal baseline renal function are at increased risk of developing contrast-induced nephropathy post-percutaneous coronary intervention.
Chong E; Poh KK; Shen L; Chai P; Tan HC
Singapore Med J; 2009 Mar; 50(3):250-4. PubMed ID: 19352566
[TBL] [Abstract][Full Text] [Related]
26. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention.
Zhang J; Fu X; Jia X; Fan X; Gu X; Li S; Wu W; Fan W; Su J; Hao G; Jiang Y; Xue L
Acta Radiol; 2010 Jul; 51(6):641-8. PubMed ID: 20438292
[TBL] [Abstract][Full Text] [Related]
27. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.
Wang XC; Fu XH; Wang YB; Jia XW; Wu WL; Gu XS; Zhang J; Su JL; Hao GZ; Jiang YF; Fan WZ; Li SQ
Chin Med J (Engl); 2011 Mar; 124(6):892-6. PubMed ID: 21518598
[TBL] [Abstract][Full Text] [Related]
28. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
Kim BJ; Sung KC; Kim BS; Kang JH; Lee KB; Kim H; Lee MH
Int J Cardiol; 2010 Feb; 138(3):239-45. PubMed ID: 18793808
[TBL] [Abstract][Full Text] [Related]
29. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
[TBL] [Abstract][Full Text] [Related]
30. Serious renal dysfunction after percutaneous coronary interventions can be predicted.
Brown JR; DeVries JT; Piper WD; Robb JF; Hearne MJ; Ver Lee PM; Kellet MA; Watkins MW; Ryan TJ; Silver MT; Ross CS; MacKenzie TA; O'Connor GT; Malenka DJ;
Am Heart J; 2008 Feb; 155(2):260-6. PubMed ID: 18215595
[TBL] [Abstract][Full Text] [Related]
31. Effect of statins pretreatment on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: a meta-analysis.
Zhang F; Dong L; Ge J
Ann Med; 2010 Apr; 42(3):171-7. PubMed ID: 20384433
[TBL] [Abstract][Full Text] [Related]
32. Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials.
Liu YH; Liu Y; Duan CY; Tan N; Chen JY; Zhou YL; Li LW; He PC
J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):181-92. PubMed ID: 25193735
[TBL] [Abstract][Full Text] [Related]
33. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome.
Chyrchel M; Rakowski T; Rzeszutko L; Legutko J; Dziewierz A; Dubiel JS; Dudek D
Kardiol Pol; 2006 Dec; 64(12):1357-62; discussion 1363. PubMed ID: 17206539
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of anisodamine on prevention of contrast induced nephropathy in patients with acute coronary syndrome.
Wang YB; Fu XH; Gu XS; Wang XC; Zhao YJ; Hao GZ; Jiang YF; Fan WZ; Wu WL; Li SQ; Xue L
Chin Med J (Engl); 2012 Mar; 125(6):1063-7. PubMed ID: 22613532
[TBL] [Abstract][Full Text] [Related]
35. The role of theophylline in prevention of radiocontrast media-induced nephropathy.
Malhis M; Al-Bitar S; Al-Deen Zaiat K
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):276-83. PubMed ID: 20228513
[TBL] [Abstract][Full Text] [Related]
36. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.
Dangas G; Iakovou I; Nikolsky E; Aymong ED; Mintz GS; Kipshidze NN; Lansky AJ; Moussa I; Stone GW; Moses JW; Leon MB; Mehran R
Am J Cardiol; 2005 Jan; 95(1):13-9. PubMed ID: 15619387
[TBL] [Abstract][Full Text] [Related]
37. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
Nyman U; Björk J; Aspelin P; Marenzi G
Acta Radiol; 2008 Jul; 49(6):658-67. PubMed ID: 18568558
[TBL] [Abstract][Full Text] [Related]
38. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
[TBL] [Abstract][Full Text] [Related]
39. Impact of automated contrast injector systems on contrast use and contrast-associated complications in patients undergoing percutaneous coronary interventions.
Gurm HS; Smith D; Share D; Wohns D; Collins J; Madala M; Koneru S; Menees D; Chetcuti S
JACC Cardiovasc Interv; 2013 Apr; 6(4):399-405. PubMed ID: 23523450
[TBL] [Abstract][Full Text] [Related]
40. Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy.
Call J; Sacrinty M; Applegate R; Little W; Santos R; Baki T; Gandhi S; Kahl F; Kutcher M
J Invasive Cardiol; 2006 Oct; 18(10):469-74. PubMed ID: 17042103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]